So, Palantir Technologies Inc. (PLTR) shares are having a pretty good Monday. They're up more than 5%, and when a stock that's already had a huge run—up over 63% in the last year—keeps climbing, you want to know why. It turns out there are two main stories here: one about the U.S. military locking in a big AI contract, and another about the world getting a little less tense for a moment.

The Geopolitical Sigh of Relief

First, the broader market breathed a sigh of relief. Over the weekend, there was some serious tension involving Iran and the Strait of Hormuz. But on Monday, former President Donald Trump signaled a five-day pause on planned U.S. strikes. He posted on Truth Social that recent discussions with Iranian officials were "very good and productive." It's one of those moments where the market hates uncertainty more than anything, so even a temporary de-escalation can give stocks a lift. Palantir, with its deep ties to government and defense, tends to move with these kinds of geopolitical winds.

The Real Meat: The Pentagon's AI Bet

But the bigger, more concrete driver for Palantir is defense spending, not diplomacy. According to reports, the Pentagon is making a major commitment. Deputy Secretary of Defense Steve Feinberg issued a directive on March 9 for the Department of Defense to formally adopt Palantir's Maven Smart System across all military branches.

This isn't just a pilot program or a test. This is the Pentagon saying, "We're buying this." The Maven system is an AI-powered platform designed for weapons targeting and intelligence analysis. Locking in long-term funding for it is a huge deal for Palantir. It validates their technology in the most demanding environment possible and provides a steady, predictable revenue stream from their biggest customer. For a company that has spent years convincing skeptics about its commercial business, a flagship military AI contract is a powerful counter-argument.

What the Charts Are Saying

Let's look at the technical picture. The stock is trading about 7.3% above its 20-day simple moving average. That suggests improving short-term momentum—buyers are stepping in. However, it's still trading about 4.7% below its 100-day moving average. That tells you the intermediate-term trend isn't fully healed yet; there's still some overhead resistance to work through.

The Relative Strength Index (RSI) is at 50.63, which is right in neutral territory—not overbought, not oversold. The MACD indicator is flashing a bullish signal, with the MACD line (1.7243) sitting above the signal line (0.7735).

For traders watching key levels:

• Key Resistance: $161.50
• Key Support: $148.00

Breaking above that $161.50 resistance could open the door for a run toward the 52-week highs.

The Analyst Bull Case

Wall Street analysts, for the most part, are still fans. The stock carries a consensus Buy rating with an average price target of $167.56. That implies a decent chunk of upside from current levels. The bullishness has been reinforced by several recent moves:

• UBS: Reiterated a Buy rating and raised its price target to $200.00 (March 18).
• Wedbush: Maintained an Outperform rating with a $230.00 target (March 16).
• Rosenblatt: Reiterated a Buy and raised its target to $200.00 (March 3).

The targets from Wedbush and UBS suggest some analysts see a path for the stock to gain 25-45% from here. They're betting on the company's government business staying strong and its commercial AI software, AIP, gaining more traction.

Looking Ahead to the Next Catalyst

The next scheduled event that could really move the needle is the earnings report. The current estimate is for that to land around May 4, 2026. The expectations baked into that report are steep:

• EPS Estimate: 26 cents (That's double the 13 cents from a year earlier)
• Revenue Estimate: $1.54 billion (Up significantly from $880 million year-over-year)

Those growth numbers are impressive, but they come at a price. The stock trades at a sky-high P/E ratio of 239.2x estimated earnings. Investors are paying a massive premium for that expected growth. Any stumble in hitting those targets could be punished severely. Conversely, beating them could justify the valuation and send the stock higher.

At the time of publication, Palantir shares were up 5.39%, trading at $158.79.